Vironix discusses chronic lung diseases at the 2021 University Of Vermont MPI Workshop

Vironix team members attended the 2021 University Of Vermont MPI Workshop on June 14th - 18th.

MPI (mathematical problems industry)  is a problem solving workshop that attracts leading applied mathematicians and scientists from universities, and international laboratories. During the workshop, engineers and scientists interact with the academic participants on problems of interest to their companies.

Main missions of MPI are:

• Help companies meet their technological challenges
• Provide graduate students with experience of working on real-world applications.

The MPI Workshop is a lively, 5-day interaction on problems of interest to science and industry. On the first day, the industry representatives present their problems to the whole group. These problems vary widely in nature from those requiring basic physical modeling to those requiring significant computation. For the rest of the week, the workshop participants break up into small working groups consisting of senior faculty and attending scientists, postdoctoral fellows, graduate students, and the industrial representatives, to discuss and tackle the problems in an informal setting. On the last day of the workshop, an academic representative from each group presents the results obtained and discusses possible future directions. A written report detailing the progress made during the workshop is prepared subsequently and sent to the industry representatives. Upon approval by the industry representative, the reports are posted online.

Our Presentation discussed utilizing clinical data to predict the severity of presentation of chronic lung diseases.  Exacerbations of chronic lung disease account for ~ $70 billion of an astounding $130 billion in annual US direct costs from COPD (chronic obstructive pulmonary disease) and Asthma alone. The lack of accurate, automated, and personalized approaches for self-identification and early care of these illnesses has led to unnecessary healthcare utilization, unmitigated infection spread, increased morbidity, and missed opportunities for timely therapeutic intervention. To view our presentation & documents please CLICK HERE

When the final report is available we will post the document on this page.  Please check back soon.